The store will not work correctly when cookies are disabled.
(4-(3-bromo-5-(trifluoromethyl)phenyl)thiazol-5-yl)(2-chlorophenyl)methanone
ID: ALA4289114
PubChem CID: 145989697
Max Phase: Preclinical
Molecular Formula: C17H8BrClF3NOS
Molecular Weight: 446.68
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(c1ccccc1Cl)c1scnc1-c1cc(Br)cc(C(F)(F)F)c1
Standard InChI: InChI=1S/C17H8BrClF3NOS/c18-11-6-9(5-10(7-11)17(20,21)22)14-16(25-8-23-14)15(24)12-3-1-2-4-13(12)19/h1-8H
Standard InChI Key: YCNNTLXYIAKFTK-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
14.0250 -24.5535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4815 -25.2382 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
15.2726 -25.0184 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.3068 -24.1977 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5367 -23.9090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.9806 -25.4237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9815 -26.2450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6879 -25.0144 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.0136 -23.7770 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7295 -24.1843 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4318 -23.7642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4228 -22.9423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.7057 -22.5422 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0022 -22.9605 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2674 -26.6559 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2679 -27.4765 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9807 -27.8851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6903 -27.4714 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.6863 -26.6522 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3963 -26.2363 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
18.1449 -24.1634 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1557 -24.9806 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.8471 -23.7455 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
18.8491 -24.5694 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
16.6944 -21.7251 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 2 0
4 5 1 0
5 1 2 0
3 6 1 0
6 7 1 0
6 8 2 0
4 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 9 1 0
7 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 7 1 0
19 20 1 0
11 21 1 0
21 22 1 0
21 23 1 0
21 24 1 0
13 25 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 446.68 | Molecular Weight (Monoisotopic): 444.9151 | AlogP: 6.48 | #Rotatable Bonds: 3 |
Polar Surface Area: 29.96 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: ┄ | CX Basic pKa: 0.38 | CX LogP: 6.51 | CX LogD: 6.51 |
Aromatic Rings: 3 | Heavy Atoms: 25 | QED Weighted: 0.43 | Np Likeness Score: -1.61 |
References
1. Doebelin C, Patouret R, Garcia-Ordonez RD, Chang MR, Dharmarajan V, Novick S, Ciesla A, Campbell S, Solt LA, Griffin PR, Kamenecka TM.. (2018) Identification of potent RORβ modulators: Scaffold variation., 28 (19): [PMID:30143422] [10.1016/j.bmcl.2018.08.017] |